Bunge Global vs AbbVie

Side-by-side comparison of AI visibility scores, market position, and capabilities

AbbVie leads in AI visibility (90 vs 84)

Bunge Global

LeaderConsumer Goods

Enterprise

St. Louis global ag trader and processor (NYSE: BG) ~$45.8B FY2024 revenue; Viterra $8.2B acquisition pending 2025 closing, soybean crush/export, biofuel demand competing with ADM and Cargill.

AI VisibilityBeta
Overall Score
A84
Category Rank
#51 of 290
AI Consensus
75%
Trend
down
Per Platform
ChatGPT
88
Perplexity
79
Gemini
83

About

Bunge Global SA is a St. Louis, Missouri-based agricultural commodities trader and food processing company — publicly traded on the New York Stock Exchange (NYSE: BG) as an S&P 500 Consumer Staples component, incorporated in Switzerland — processing oilseeds (soybeans, canola, sunflower) into vegetable oils and protein meals for food manufacturers, animal feed producers, and biodiesel refiners; trading grains and oilseeds globally through port elevators, inland grain terminals, and trading offices; and producing edible oils and specialty fats for consumer food brands through approximately 30,000 employees in 40+ countries. In fiscal year 2024, Bunge reported revenues of approximately $45.8 billion (declining from the 2022 commodity price peak as soybean crush margins normalized from supercycle levels), with adjusted EBITDA of approximately $1.5 billion from the Agribusiness, Refined Oils, and Milling segments. CEO Greg Heckman's defining strategic transaction: the pending acquisition of Viterra (Glencore's agricultural trading arm, formerly Viterra — handling grain, oilseed, and specialty crops origination and processing from Canada, Australia, and Europe) for $8.2 billion, announced in June 2023 and working through global competition authority approvals through 2024-2025 — creating a combined company with $60+ billion in combined revenues and market positions in North American, South American, European, and Australian grain origination that would rank alongside Archer-Daniels-Midland (ADM), Louis Dreyfus, and Cargill as a global agricultural trading leader. The Viterra combination (expected to close in mid-2025 after approval from EU, Canada, and Australia competition regulators) adds Viterra's Canadian canola origination (8+ million metric tons annually), Australian grain export infrastructure, and European oilseed and specialty crop handling to Bunge's Brazilian soy, US soybean, and Argentine origination platforms.

Full profile

AbbVie

LeaderHealthcare

General

Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.

AI VisibilityBeta
Overall Score
A90
Category Rank
#9 of 1167
AI Consensus
60%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
99
Gemini
83

About

AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.

Full profile

AI Visibility Head-to-Head

84
Overall Score
90
#51
Category Rank
#9
75
AI Consensus
60
down
Trend
stable
88
ChatGPT
99
79
Perplexity
99
83
Gemini
83
78
Claude
96
85
Grok
95

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.